...
机译:舌下βv 1的舌下免疫疗法后的Ige-Cross-rescling抗体v 1
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Salzburg Univ Dept Biosci Salzburg Austria;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Allergy Clin Reumannpl Vienna Austria;
Allergiezentrum Wien West Vienna Austria;
Med Univ Vienna Dept Dermatol Vienna Austria;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Salzburg Univ Dept Biosci Salzburg Austria;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
Med Univ Vienna Ctr Pathophysiol Infectiol &
Immunol Dept Pathophysiol &
Allergy Res Waehringer;
allergenamp; 8208; specific immunotherapy; Bet v 1; birch pollenamp; 8208; related allergy; crossamp; 8208; blocking antibodies; IgEamp; 8208; blocking IgG antibodies;
机译:对桦木和Fagales花粉提取物吸附在氢氧化铝上的皮下注射免疫疗法诱导的抗体反应进行分析。
机译:皮下免疫疗法抑制Th2炎症并诱导中和抗体,但舌下免疫疗法抑制了草花粉小鼠模型的气道高反应性,用于过敏性哮喘
机译:用桦木花粉相关苹果过敏患者患有4个月舌下免疫治疗4个月的舌下免疫疗法的疗效和安全性
机译:在桦木花粉过敏患者中过敏原特异性免疫疗法期间对次要过敏原BβV2的抗体反应
机译:重组抗体用于肿瘤免疫治疗的产生。
机译:免疫疗法:螨过敏性儿童舌下免疫疗法后201的临床疗效和黏膜/全身抗体反应变化:巴西一项双盲安慰剂对照的随机研究
机译:舌下β与重组下注V 1后舌下免疫疗法的抗体抗体抗体
机译:基于抗体的免疫疗法和节律化疗联合靶向前列腺癌细胞和肿瘤相关周细胞